Herpes zoster oticus: treatment with acyclovir.
Herpes zoster oticus produces facial paralysis with a low recovery rate. Acyclovir, a specific virostatic drug, was given intravenously in five herpes zoster oticus patients, and in three of them was followed by oral therapy. In follow-ups of 1 to 24 months, one patient had grade I recovery, three patients grade II, and one grade III. These good results encourage the use of acyclovir in herpes zoster oticus patients.
Uri
N
N
Department of Otolaryngology, Lady Davis Carmel Hospital, Haifa, Israel.
Greenberg
E
E
Meyer
W
W
Kitzes-Cohen
R
R
D000212:Acyclovir / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005500:Follow-Up Studies; D016697:Herpes Zoster Oticus / Q000188:drug therapy*; D006801:Humans; D012074:Remission Induction
D000212:Acyclovir